Member Info for JustHereForHemo

Alde, we don't care, we would like you to sell and stick to Avacta.

Soooo many posts targeting me I feel I HAVE to respond.

https://www.lse.co.uk/profiles/notposting/ - You really have just created this account because of your obsession with me, you do need to move on at some point, seriously go find a local club and try Pickleball?

Hope you do, try not to spend all weekend obsessing over me, if it makes you feel any better I have a massive mortgage and I am sure your net worth is much bigger than mine if thats what your worried about? Anyway, This is pinky promise last post for today, ironically you have probably achieved the opposite of what you intended. Nobody here is talking about the science, its just bs personal attacks. Any LTHer I know has no time for LSE and traders are off chasing shares with more volume. People are not coming here for advice or insight or science but purely out of habit. Time to move on, if you want buy then buy, if you want to short then short, I really dont care!

Cyrox, I will pass comment here once today, agree or disagree its not a discussion just my opinion.

The placess from the last 3 placings (inc the CLN) are not selling, we saw a TR1 and will likely see a TR1 when the CLN converts. None of the warrants from these placings were executed so lets exclude them from what I say next.

The PRIOR placings, the ones that started the 180+ adjustable warrants? They came from as I understand it Singer Capital and Marex, when they happened the shares were dumped, often at a small loss, blocks of 80k shares some times, all the shares were churned leaving risk free warrants. Following the significant rise last month one entire tranche of warrants were forward sold into the rise and converted giving the MMs a much needed lifeline when they had ZERO stock. Toxic? Frustrating? Dirty? All of the above. It happened. There was another partial conversion also using up all available headroom Vlad had to issue shares.

Since then? When Tilly was here posting the official short position from Ortex it was growing by a few thousand daily and had been since the SP was high, not closing when SP bounced, not closing when SP had tanked, As he stated and many of us now accept, this is almost without doubt a warrant holder forward selling his warrants until Vlad has headroom to convert and close out. Is it unreasonable??? No, one warrant holder has £5 warrants that expire in a few months if not sold now, so what do people expect? Let them expire?

https://www.lse.co.uk/rns/HEMO/placing-to-raise-163451250-and-director8217s-dealing-a4s26nf0fxbtulp.html

https://www.lse.co.uk/rns/HEMO/institutional-investment-4p9wkg4nu54doq4.html - Half have been converted

https://www.lse.co.uk/rns/HEMO/placing-to-raise-163340000-47uvhmg3veb9c91.html

^ These are the outstanding warrants that PROBABLY belong to MMs/Institutions/Traders, I can guess at some and have no faith in any of them. The recent non stop 1k sells? I have no doubt it was a placee forward selling these warrants. When there is headroom in a few weeks? I fully expect to see a warrant conversion closing out those shorts, for info Headroom becomes available 15th November.

IF correct? Its not about the science, its not about personalities, its not about potential. Its someone sitting with a spreadsheet and a warrant looking at unrealised profit realising profit.

Now the questions for shareholders/traders and the like...

1, Am I correct?

2, What difference does it make?

3, How many share have been sold in relation to the available upcoming headroom?

4, On the day that these traders finally run out of warrants to cover short selling what happens?

5, If news lands now with so many warrants already sold and headroom reserved what will happen?

For the record I have no hard proof of any of this so do your own research. If I am right in a few weeks there will be an RNS confirming warrant conversion AND the date they were issued.

Thank you Alde 😊 for conformation of your position.

HFH, maybe worth clarifying that's from point of diagnosis with alternative treatment. All our patients were diagnosed months prior to getting HG-CT-1 and certainly for p1 there was no alternative available.

"are you really happy"?

If its frustrating you then yes, absolutely yes, from the bottom of my heart and with every ounce of my being yes, yes and yes.

If the traders are complaining about lack of information on which to trade then my bosom overflows with joy.

So.... Yes.

TW has moved on, so should we.

Ignore the drama and live your life. Days tick by and the value here grows. What people say here or twitter just doesn't matter any more.

I assure you I have ZERO interest in trolling other shares, it's sad and pathetic.

I also love how desperate the trolls are to dedicate so many hours on the weekend.

And again, it's worth highlighting they are busy with character assination instead of attacking Hemo or the science. THIS is a very good sign. Looking forward to the days and weeks ahead 🔥

On my phone,cba a long reply, one of us is nervous about our investment and trying to cross ramp, the other is not. Have a good weekend 😜

First and foremost we Hemogenyx shareholders do not deramp other shares, especially not Avacta as many shareholders here also hold it. Discussing here is one thing, but please never cross the line to deramp there.

Regarding retaining 100%..... shareholders in every share use that old chestnut to passify themselves as the accept the inevitable back passage widening as the 3 sisters take turns.

If your mCap is 60m like us and a very cheap license deal is 600m? That's 1000%, over £100 per share. It's a ridiculous cheap price to buy HG-CT-1 but one shareholders would accept. 600m license for Avacta shareholders? That's only double the mCap, it's not going to do 1000%. MCap matters.

When Discussing likelihood of placings etc you MUST discuss cash burn.

Hemogenyx slashed overheads, most staff gone, outsourced CAR-T manufacturing and will be paid by cellin for every patient in Estonia. Vs Avacta that have to raise MORE than Hemogenyx cash burn per month purely to furnish the CLN. It's like the UK taxing those of us who pay taxes up the wazoo with 90% of that just going to pay the country's credit card interest payment.

Avacta have something that's worth bringing to patients and could help save lives, but it's apples and oranges, one is a relatively low risk and low cash burn investment in a near term multi bagger, the other is not.

Good luck pumpkin.. to you and your liver!

Worth flipping it on its head.

How fantastic is it that the trolls have literally nothing about Hemogenyx to attack. In the science there is zilch they can attack, occasionally they will try and compare apples to oranges or try and distract.

Mostly recently it's just attempted character assignation of shareholders. But that's it. A good place to be

Brenda? Err excuse me? Ulterior motives? I think I have always been transparent having posted for many many years with the exact same message.

Support hemo

Hemo do well

Make lots of money when eventually licence.

I also know HFH who yea has traded but has still supported the company and HT, has been a right pain in the as.... but he is genuine for his part and been here for years.

There are other hemo screen names like HEMOREALISM which were just the troll alternative profile for the purposes of shorting and trading. Can't control what others call themselves.

But to your original point.

The people with Hemo in their name by and large have one share that they actually care about and it's Hemogenyx and we don't give a toss about HE1 or any other dogs.

Alde, I'm sorry but categorically you are wrong.

Let me compare this to World of War craft or any online leveling game. They are designed to reward early stage game play, kill an NPC on day one and you gain 100 levels, after 7 years? You have to kill millions to gain one level.

Starting position matters. Hemogenyx is a fraction of the mCap of Avacta and I know you hate to do this but you have to compare mCaps. Hemogenyx have a CAR-T with average licensing potential of 10-20 times current mCap at early stage clinical, that's conservative and ignores CDX and CBR. Licensing or JV imminent let along direct commercialisation in Estonia.

Now compare that with Avacta.... 300m mcap targeting HOPEFULLY a few bn licensing??? To do so they need to prove BETTER than standard of care. That means comparable testing which is years and very expensive before they are a target, I have every hope and believe they will do well bit they are competing to beat the standard of care, we are competing against ourselves to be the standard of care.and when you look at the financial side? Avacta have huge future dilution to consider with CLNs which effectively rule out multibag potential until cleared, basically fully diluted the MCap is already significantly north of 300m. Yes sure they are making chemo less toxic and more targeted, that's great.... it's still chemo, you call out the risk of Hemo being out done by competitors well the world is trying to move on from chemo... so... yea.

But I'm not putting down Avacta, 100% hope they succeed, just like I believe you when you say you like what Hemogenyx have.

What I am saying is your completely disregarding the timelines and state of play and likelihood of significant movement in both hemo and Avacta based purely on where your money is sitting any day of the week. By your own admission your trading, like a game of flogger trying to cross the river on floating logs going each direction, your trading 2 stocks and trying to maximise your gain. That's an incredibly difficult thing to do, chances are external forces will happen that are positive for BOTH hemo and avacta and both will move up*(or down) in unison.

Stop trying to manipulate people, you know this is all true, people should diversify their PF and if people want to invest in Avacta? Good luck to them, none of us know what either company will announce next. But bottom like, on paper, Hemogenyx have the greater upside PERCENTAGE GAIN potential in the shortest time frame. And now? Off for the day.

Well said Micky!

He1??? What are you on about?

Assuming Vlad does not need money via placing again, what difference would increased PR or signposting make to Hemogenyx? Serious question. How does it help the trials or licensing discussions?

He has had reassurance that people will convert warrants if asked to inject cash so assume he doesn't need to place, why should he care about signposting what's coming? Why would that make the risk from competition greater? Surely working in stealth mode gives competition a false sense of security and makes them less likely to expedite.

Alde, it's not paranoia, it's pure and utter justice.

Point blank I want anyone who is using leverage to short sell Hemogenyx to be burnt.

I want anyone who calls themselves a LTH who has sold to go trade elsewhere expecting to buy back in later to be caught out and miss on the next big rise.

I want warrant holders who may be selling to finish selling the day before transformative news.

I want LTHers and recent TR1ers who have not traded or shorted or trolled to win, to see returns that set records.

This is what I want,and the best chance for this to happen is if there are no sign posts. No hints. No leaks.

It's not what you want, fine, I get it. I also don't want sushi or rare steak, I am entitled to my opinion.

A road map is great to trade.

Call me selfish but I want to make millions and leave traders sitting wondering what the hell happened and kicking themselves for missing the boat.

I am applying exactly ZERO pressure on Vlad to release any news *(not that it would make much difference)

But so we are clear, I am 100% confident and Vlad has my 100% support.

Alde. Hemo are shortcutting to commercialisation, you want to see a deal sooner rather than later? No better way to light a fire under the arse of big pharma.